Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
1.
Healthcare (Basel) ; 12(15)2024 Aug 03.
Artigo em Inglês | MEDLINE | ID: mdl-39120244

RESUMO

Falls are among the top 10 causes of years lived with disability in people aged 75 and over. Preventive programs like case management (CM) are crucial. OBJECTIVES: To evaluate the effects of a multifactorial fall prevention program based on CM on physical performance, the presence of pain, and the risk of falls and fractures in older people who have suffered falls. METHODS: This randomized, single-blind clinical trial with parallel groups, Intervention Group (IG) and Control Group (CG), was composed of 55 older people with a history of falling, living in the community. All participants underwent an initial assessment via video call (containing anamnesis, timed up-and-go test, falls risk score, short physical performance battery, and clinical frax). The IG underwent CM, the physical exercise protocol, and the cognitive stimulation protocol. The CG was monitored through telephone calls and received general health and fall guidance. RESULTS: No significant results were found in the physical capacity, the presence of pain, the risk of falls, or the fractures between the Intervention and Control Groups and between assessments. CONCLUSION: This program was not effective in improving functional performance, but it was important for characterizing pain and the probability of fracture in the next 10 years in this population.

2.
Psychogeriatrics ; 24(5): 1111-1119, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39039430

RESUMO

BACKGROUND: Falls are directly related to morbidity and mortality of older people. Multifactorial approaches that are individualised and based on fall risk factors are necessary. This study aims to verify the effects of a case management-based intervention on non-motor risk factors for falls in community-dwelling older people with a history of falls. METHODS: The intervention applied a multidimensional assessment of risk factors for falls, a discussion about the identified risk factors, the preparation of an individualised plan with the participant, and the application, monitoring and review of the plan. RESULTS: There was a significant interaction between groups and assessments only in the visuospatial domain (P = 0.031). After simple main effects analysis, differences between groups and assessments were not significant, although there was a tendency of worse visuospatial performance in the control group in the follow-up assessment (P = 0.099). There were no significant differences between groups or between assessments in other variables. CONCLUSION: The intervention has the potential to maintain non-motor risk factors for falls in community-dwelling older people with a history of falls. However, more clinical trials are needed to prove its effects.


Assuntos
Acidentes por Quedas , Administração de Caso , Vida Independente , Humanos , Acidentes por Quedas/prevenção & controle , Acidentes por Quedas/estatística & dados numéricos , Idoso , Masculino , Feminino , Fatores de Risco , Idoso de 80 Anos ou mais , Avaliação Geriátrica/métodos
3.
Genes (Basel) ; 14(10)2023 10 04.
Artigo em Inglês | MEDLINE | ID: mdl-37895255

RESUMO

Lung cancer is a highly aggressive neoplasm and, despite the development of recent therapies, tumor progression and recurrence following the initial response remains unsolved. Several questions remain unanswered about non-small cell lung cancer (NSCLC): (1) Which patients will actually benefit from therapy? (2) What are the predictive factors of response to MAbs and TKIs? (3) What are the best combination strategies with conventional treatments or new antineoplastic drugs? To answer these questions, an integrative literature review was carried out, searching articles in PUBMED, NCBI-PMC, Google Academic, and others. Here, we will examine the molecular genetics of lung cancer, emphasizing NSCLC, and delineate the primary categories of inhibitors based on their molecular targets, alongside the main treatment alternatives depending on the type of acquired resistance. We highlighted new therapies based on epigenetic information and a single-cell approach as a potential source of new biomarkers. The current and future of NSCLC management hinges upon genotyping correct prognostic markers, as well as on the evolution of precision medicine, which guarantees a tailored drug combination with precise targeting.


Assuntos
Carcinoma Pulmonar de Células não Pequenas , Neoplasias Pulmonares , Humanos , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Carcinoma Pulmonar de Células não Pequenas/genética , Carcinoma Pulmonar de Células não Pequenas/metabolismo , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/tratamento farmacológico , Neoplasias Pulmonares/genética , Prognóstico , Resistencia a Medicamentos Antineoplásicos/genética , Receptores ErbB/genética , Inibidores de Proteínas Quinases/farmacologia , Mutação
4.
Rev. bras. educ. espec ; 29: e0155, 2023. tab, graf
Artigo em Português | LILACS-Express | LILACS | ID: biblio-1529755

RESUMO

RESUMO Este estudo teve como objetivo: (I) identificar o estado de arte das publicações sobre intervenções assistida por animais (IAA) na América Latina; e (II) realizar a avaliação crítica da qualidade metodológica dos estudos clínicos sobre IAA na América Latina. Trata-se de uma revisão de escopo. Os dados foram coletados nas bases Redalyc, SciELO, LILACS, Periódicos CAPES e BIREME. Atenderam aos critérios de elegibilidade 146 artigos, sendo 34 submetidos ao Método de Avaliação Crítica de Estudos da Colaboração Cochrane. Os estudos abrangeram o período de 1997 a 2021, principalmente produzidos no Brasil, com delineamentos do tipo estudos de revisão, de caso e descritivo. Em relação aos estudos clínicos, a população infantil foi o maior público submetido às IAA. Equinos e canídeos e representaram as principais espécies de coterapeutas. Parte significativa dos estudos de intervenção demonstrou critérios de replicabilidade, porém constatou-se a ausência de rigor metodológico, limitando a possibilidade de avaliação da eficácia das intervenções. Este estudo aponta o potencial uso da IAA na América Latina e aumento do número de produções ao longo do tempo; todavia, sugere-se que estudos futuros privilegiem a utilização de metodologia experimental, como os ensaios clínicos randomizados, de forma a permitir a avaliação da eficácia das IAA.


ABSTRACT This study aimed to: (I) to identify the state of the art of publications on animal-assisted interventions (AAI) in Latin America; and (II) to critically evaluate the methodological quality of clinical studies on AAI in Latin America. This is a scoping review. Data were collected from Redalyc, SciELO, LILACS, CAPES Journal Portal and BIREME. Eligibility criteria allowed the inclusion of 146 articles, 34 of which were submitted to the Cochrane Collaboration Method of Critical Appraisal of Studies. The studies covered the period from 1997 to 2021, mainly produced in Brazil, and designed as review, case, and descriptive studies. Regarding clinical studies, the child population was the largest population submitted to AAI. Horses and canidae represented the main cotherapists species. A significant part of the intervention studies demonstrated replicability criteria; however, there was a lack of methodological rigor, limiting the possibility of evaluating the effectiveness of the interventions. This study points to the potential use of AAI in Latin America and an increase in the number of studies over time; however, it is suggested that future studies should emphasize the use of experimental methodology, such as randomized clinical trials, in order to allow the evaluation of the effectiveness of AAI.

5.
Estud. pesqui. psicol. (Impr.) ; 22(4): 1663-1686, dez. 2022.
Artigo em Inglês, Espanhol, Português | LILACS | ID: biblio-1428541

RESUMO

O trabalho em saúde no campo do HIV/Aids requer uma abordagem interdisciplinar e tem como desafios fundamentais a adesão da população aos métodos e medidas de prevenção e tratamento, assim como a efetivação do acesso e da integralidade na assistência, o enfrentamento à discriminação e à estigmatização das populações-chave e das pessoas que vivem com HIV. Além disso, ele mobiliza questões complexas relacionados à sexualidade e ao exercício da autonomia cidadã. Tendo isso em vista, analisamos neste trabalho dezoito protocolos clínicos que instruem a atuação profissional na assistência ao HIV/Aids, pautando temas a serem abordados e procedimentos para qualificar o atendimento. Realizamos uma revisão integrativa buscando elucidar o entendimento dos diretos sexuais e reprodutivos presente nestes documentos. Com a síntese dos resultados obtidos, organizamos três categorias a partir das quais são desenvolvidos a temática dos direitos sexuais e reprodutivos: vulnerabilidade; autonomia; gênero e diversidade sexual. Concluímos que os tópicos da vulnerabilidade, reiteradamente abordado, e da sexualidade, que coloca progressivamente em questão a desnaturalização dos papéis sociais de gênero, buscam convergir aspectos sociais, culturais e individuais, indicando um aprimoramento das práticas de promoção de autonomia e a efetivação dos direitos sexuais e reprodutivos na assistência ao HIV/Aids.


Health work in the field of HIV/AIDS requires an interdisciplinary approach and has as fundamental challenges the population's adherence to prevention and treatment methods and measures, as well as the effective access and integrality in assistance, and the struggle against discrimination and stigmatization of key-populations and people living with HIV. In addition, it mobilizes complex issues related to sexuality and the exercise of citizenship autonomy. Considering this, we analyzed in this work eighteen clinical protocols that guide professional performance in HIV/AIDS care, organizing themes and procedures to qualify the care. We performed an integrative review to elucidate the understanding of sexual and reproductive rights present in these documents. With the synthesis of the results obtained, we organized three categories from which the theme of sexual and reproductive rights is developed: vulnerability; autonomy; gender and sexual diversity. We conclude that the topics of vulnerability, repeatedly addressed, and sexuality, which progressively questions the naturalization of social gender roles, try to converge social, cultural and individual aspects, indicating an improvement of practices that promotes sexual and reproductive autonomy and enforcement of rights in HIV/AIDS care.


El trabajo en salud en el campo del VIH/SIDA requiere un abordaje interdisciplinario y tiene como desafíos fundamentales la adhesión de la población a los métodos y medidas de prevención y tratamiento, así como el acceso efectivo y la atención integral, combatiendo la discriminación y estigmatización de las poblaciones-clave y de las personas que viven con el VIH. Además, moviliza temas complejos relacionados con la sexualidad y el ejercicio de la autonomía ciudadana. Considerando eso, analizamos dieciocho protocolos clínicos que orientan la actuación profesional en la atención al VIH/SIDA, orientando temas a ser abordados y procedimientos para calificar la atención. Realizamos una revisión integrativa buscando elucidar la comprensión de los derechos sexuales y reproductivos presente en estos documentos. Con la síntesis de los resultados obtenidos, organizamos tres categorías con las cuales se desarrolla la temática de los derechos sexuales y reproductivos: vulnerabilidad; autonomía; género y diversidad sexual. Concluimos que los temas vulnerabilidad, repetidamente abordado, y sexualidad, que progresivamente cuestiona la naturalización de los roles sociales de género, buscan converger aspectos sociales, culturales e individuales, indicando una mejora de las prácticas de promoción de la autonomía y la efectuación de los derechos sexuales y reproductivos en la atención del VIH/SIDA.


Assuntos
Humanos , Atitude do Pessoal de Saúde , Protocolos Clínicos , Síndrome da Imunodeficiência Adquirida , HIV , Direitos Sexuais e Reprodutivos , Saúde Sexual , Brasil , Pessoal de Saúde , Vulnerabilidade em Saúde , Diversidade de Gênero , Identidade de Gênero , Política de Saúde
6.
JMIR Res Protoc ; 11(6): e34796, 2022 Jun 13.
Artigo em Inglês | MEDLINE | ID: mdl-35700005

RESUMO

BACKGROUND: Individual case management programs may be particularly effective in reducing fall risk as they can better identify barriers and facilitators to health recommendations. OBJECTIVE: This paper describes the protocol for a single-blind, parallel-group randomized controlled trial that aims to investigate the effectiveness and cost-effectiveness of a home-based multifactorial program targeting fall risk factors among people aged 60 years and over who have fallen at least twice in the past 12 months (the MAGIC trial). METHODS: Older people with a history of at least 2 falls in the last year will be divided into 2 groups. The intervention group will receive case management at home for reducing the risk of falls, including a multidimensional assessment, explanation of fall risk factors, and elaboration and monitoring of an individualized intervention plan based on the identified fall risk factors, personal preferences, and available resources. The control group will be monitored once a month. Assessments (clinical data, fall risk awareness, physical and mental factors, safety at home, feet and shoes, and risk and rate of falls) will be carried out at baseline, after 16 weeks of the intervention, and at the posttrial 6-week and 1-year follow-up. After 16 weeks of the intervention, satisfaction and adherence to the intervention will also be assessed. Economic health will be evaluated for the period up to the posttrial 1-year follow-up. RESULTS: Data collection started in April 2021, and we expected to end recruitment in December 2021. This case management program will address multifactorial assessments using validated tools and the implementation of individualized intervention plans focused on reducing fall risk factors. CONCLUSIONS: This trial may provide reliable and valuable information about the effectiveness of case management for increasing fall risk awareness and reducing fall risk in older people. TRIAL REGISTRATION: Brazilian Clinical Trials Registry (ReBec) RBR-3t85fd; https://ensaiosclinicos.gov.br/rg/RBR-3t85fd. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/34796.

7.
Cien Saude Colet ; 26(10): 4783-4794, 2021 Oct.
Artigo em Português, Inglês | MEDLINE | ID: mdl-34730663

RESUMO

This article aims to evaluate the conformity between drug package inserts (DPIs) and evidence-based bibliographic sources regarding the presence of contraindications to the use of contraceptives and anti-infective agents during breastfeeding. Contraceptive and anti-infectives were selected, according to ATC, with the updated record in the ANVISA and present in the bibliographic sources Breastfeeding and Use of Medicines and Other Substances, Medications and Mother's Milk, LactMed®, Micromedex® and UpToDate®. Information was extracted from the DPI "Contraindications" and "Warnings and precautions" sections and compared with the information in the bibliographic sources. The contraindication of the drug during breastfeeding was evaluated. Contraindications were found in the DPIs of five (55.5%) of the nine contraceptives. The contraindication percentage ranged from 0 to 55.5% among the bibliographic sources, depending on the source. The percentage was 46.3% in the DPIs, ranging from 0 to 12.9% in the bibliographic sources for anti-infectives. There is an agreement between the DPIs and the bibliographic sources regarding contraceptives; regarding anti-infectives, the DPIs are more often contraindicated for use during breastfeeding.


O objetivo deste artigo é avaliar a concordância entre bulas e fontes bibliográficas baseadas em evidências científicas quanto à presença de contraindicação do uso de anticoncepcionais e anti-infecciosos durante a amamentação. Foram selecionados medicamentos anticoncepcionais e anti-infecciosos, segundo a ATC, com registro na ANVISA e presentes nas fontes bibliográficas: Manual Amamentação e Uso de Medicamentos e Outras Substâncias, Medications and Mother's Milk, LactMed®, Micromedex® e UpToDate®. As informações foram extraídas das seções "Contraindicações" e "Advertências e precauções" das bulas e comparadas com as informações das fontes. Foi avaliada a presença de informação contraindicando o uso do medicamento durante a amamentação. Em cinco (55,5%) dos nove anticoncepcionais foi verificada contraindicação na bula. Entre as fontes bibliográficas, o percentual variou de 0% a 55,5%, dependendo da fonte. Para os anti-infecciosos, o percentual de contraindicação foi de 46,3% na bula, variando de 0% a 12,9% nas fontes. Existe concordância entre as bulas e as fontes bibliográficas com relação aos anticoncepcionais; no caso dos anti-infecciosos, as bulas apresentam contraindicação para o uso durante a amamentação com mais frequência.


Assuntos
Anti-Infecciosos , Preparações Farmacêuticas , Aleitamento Materno , Anticoncepcionais , Rotulagem de Medicamentos , Feminino , Humanos
8.
Ciênc. Saúde Colet. (Impr.) ; 26(10): 4783-4794, out. 2021. tab, graf
Artigo em Inglês, Português | LILACS | ID: biblio-1345703

RESUMO

Resumo O objetivo deste artigo é avaliar a concordância entre bulas e fontes bibliográficas baseadas em evidências científicas quanto à presença de contraindicação do uso de anticoncepcionais e anti-infecciosos durante a amamentação. Foram selecionados medicamentos anticoncepcionais e anti-infecciosos, segundo a ATC, com registro na ANVISA e presentes nas fontes bibliográficas: Manual Amamentação e Uso de Medicamentos e Outras Substâncias, Medications and Mother's Milk, LactMed®, Micromedex® e UpToDate®. As informações foram extraídas das seções "Contraindicações" e "Advertências e precauções" das bulas e comparadas com as informações das fontes. Foi avaliada a presença de informação contraindicando o uso do medicamento durante a amamentação. Em cinco (55,5%) dos nove anticoncepcionais foi verificada contraindicação na bula. Entre as fontes bibliográficas, o percentual variou de 0% a 55,5%, dependendo da fonte. Para os anti-infecciosos, o percentual de contraindicação foi de 46,3% na bula, variando de 0% a 12,9% nas fontes. Existe concordância entre as bulas e as fontes bibliográficas com relação aos anticoncepcionais; no caso dos anti-infecciosos, as bulas apresentam contraindicação para o uso durante a amamentação com mais frequência.


Abstract This article aims to evaluate the conformity between drug package inserts (DPIs) and evidence-based bibliographic sources regarding the presence of contraindications to the use of contraceptives and anti-infective agents during breastfeeding. Contraceptive and anti-infectives were selected, according to ATC, with the updated record in the ANVISA and present in the bibliographic sources Breastfeeding and Use of Medicines and Other Substances, Medications and Mother's Milk, LactMed®, Micromedex® and UpToDate®. Information was extracted from the DPI "Contraindications" and "Warnings and precautions" sections and compared with the information in the bibliographic sources. The contraindication of the drug during breastfeeding was evaluated. Contraindications were found in the DPIs of five (55.5%) of the nine contraceptives. The contraindication percentage ranged from 0 to 55.5% among the bibliographic sources, depending on the source. The percentage was 46.3% in the DPIs, ranging from 0 to 12.9% in the bibliographic sources for anti-infectives. There is an agreement between the DPIs and the bibliographic sources regarding contraceptives; regarding anti-infectives, the DPIs are more often contraindicated for use during breastfeeding.


Assuntos
Humanos , Masculino , Preparações Farmacêuticas , Anti-Infecciosos , Aleitamento Materno , Anticoncepcionais , Rotulagem de Medicamentos
9.
J. coloproctol. (Rio J., Impr.) ; 40(4): 368-375, Oct.-Dec. 2020. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1143177

RESUMO

ABSTRACT Objective: Comparison of post-anesthesia recovery time in sedated patients for colonoscopy using two drug combinations: midazolam and propofol or fentanyl and propofol. Method: Fifty patients ASA I and II, from 18 to 65 years of age, candidates for elective colonoscopy under sedation administered by an anesthesiologist, were randomized in two groups: Group A (midazolam and propofol) and Group B (fentanyl and propofol). Each patient was evaluated as for the length of the exam (Exam length), length of stay in the post-anesthesia care unit 1 and 2 (LSPACU1 and LSPACU2) and hospital discharge. Episodes of awakening, and of movement, drop in SpO2 < 90%, need for mechanical ventilation, propofol consumption, heart rate (HR) and mean blood pressure (MBP) were also evaluated. Results: Patients of group B had a recovery time in LSPACU1 statistically shorter than that for those in group A. In both groups, LSPACU1 was considered inversely proportional to LSPACU2. Hospital discharge time was similar between groups. Patients of group B had a significant decrease in MBP during and at the end of the exam, when compared to the initial measurement and that during sedation. Nevertheless, this variation was lower than 20%. No adverse event was observed. All patients were discharged on the same day, with no unexpected hospitalization. Conclusions: The combined use of fentanyl and propofol for colonoscopy sedation had a post-anesthesia recovery time in LSPACU1 shorter than that with the combination of midazolam and propofol. Nevertheless hospital discharge time was similar between groups.


RESUMO Objetivo: Comparar o tempo de recuperação pós-anestésica de pacientes sedados para colonoscopia usando duas combinações de fármacos: midazolam e propofol ou fentanil e propofol. Método: Cinquenta pacientes ASA I e II, entre 18 e 65 anos, candidatos a colonoscopia eletiva sob sedação administrada por anestesiologista, foram randomizados em dois grupos: Grupo A (midazolam e propofol) e Grupo B (fentanil e propofol). Cada paciente foi avaliado quanto ao tempo de realização do exame (TExame), tempo de permanência na sala de recuperação pós-anestésica 1 e 2 (TSRPA 1 e TSRPA2) e a alta domiciliar. Episódios de despertar, movimentação, queda de SpO2 < 90%, necessidade de assistência ventilatória, consumo de propofol, frequência cardíaca (FC) e pressão arterial média (PAM) também foram avaliados. Resultados: Pacientes do grupo B apresentaram tempo de recuperação na SRPA1 inferior estatisticamente ao grupo A. Em ambos os grupos o TSRPA1 foi considerado inversamente proporcional ao TSRPA2. O tempo de alta domiciliar foi semelhante entre os grupos. Pacientes do grupo B apresentaram redução significativa na PAM no tempos exame e final, em relação ao inicial e sedação. Entretanto, essa variação foi inferior a 20%. Não foram observados eventos adversos. Todos os pacientes evoluíram com alta domiciliar no mesmo dia, sem ocorrência de internação não prevista. Conclusões: O uso combinado de fentanil e propofol para sedação em colonoscopia produziu tempo de recuperação pós-anestésica na SRPA1 inferior a combinação midazolam e propofol. No entanto, o tempo de alta domiciliar foi semelhante entre os grupos.


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Colonoscopia/métodos , Anestesia/estatística & dados numéricos , Midazolam/administração & dosagem , Período de Recuperação da Anestesia , Propofol/administração & dosagem , Fentanila/administração & dosagem
10.
Front Aging Neurosci ; 11: 154, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31316371

RESUMO

Background and Aim: The ability to adapt gait when negotiating unexpected hazards is crucial to maintain stability and avoid falling. This study investigated cognitive, physical and psychological factors associated with gait adaptability required for obstacle and stepping target negotiation in people with Parkinson's disease (PD). Methods: Fifty-four people with PD were instructed to either: (a) avoid an obstacle at usual step distance; or (b) step onto a target at either a short or long step distance projected on a walkway two heel strikes ahead and then continue walking. Participants also completed clinical [Hoehn & Yahr rating scale; Movement Disorders Society version of the Unified Parkinson's Disease Rating Scale motor section (MDS-UPDRS-III)], cognitive [simple reaction time, Trail Making and Stroop stepping (difference between incongruent and standard Choice Stepping Reaction Time, CSRT) tests], physical [hip abductor muscle power and reactive balance (pull test from the MDS-UPDRS-III)] and psychological (Fall Efficacy Scale-International) assessments. Results: Discriminant function analysis revealed Stroop stepping test (inhibitory control) performance was the best predictor of stepping errors across the Gait Adaptability Test (GAT) conditions. Poorer executive function [Trail Making Test (TMT)] and reactive balance predicted poorer stepping accuracy in the short target condition; poorer reactive balance predicted increased number of steps taken to approach the obstacle and the long target; and poorer executive function predicted obstacle avoidance. Weaker hip abductor muscle power, poorer reactive balance, slower reaction time, poorer executive function and higher concern about falling were significant predictors of shorter step length while negotiating the obstacle/targets. Conclusion: Superior executive function, effective reactive balance and good muscle power were associated with successful gait adaptability. Executive function and reactive balance appear particularly important for precise foot placements; and cognitive capacity for step length adjustments for avoiding obstacles. These findings suggest that impaired inhibitory control contributes to stepping errors and may increase fall risk in people with PD. These findings help elucidate mechanisms for why people with PD fall and may facilitate fall risk assessments and fall prevention strategies for this group.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA